Amarin Corp Plc (AMRN)

[haysaw]

Thanks. I wouldn't discount the product (or threat) too much though. They are going after the same RX market as Vascepa too. They are a spin-off of the krill supplier Neptune Bioressources (now a subsidiary of). Capre most certainly does not resemble the OTC krill products, in strength, from which it is derived: it is a purified and concentrated formulation, probably not much different than Vascepa. I would imagine they did not reveal the EPA/DHA %'s because they didn't have to.

Stock(s) (ACST/NEPT) have been slow to react, although ACST is showing a large volume spike and steadily moving up, and NEPT is just waking up. The muted response is not surprising...these guys have been off the radar for a long while. More opportunity to load up :)